Serum Institute of India: News

25 Feb 2021


COVID-19 vaccines: SII to play huge role in mass production

British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.

19 Feb 2021


Madras HC notice to Centre in case over Covishield side-effects

The Madras High Court on Friday issued a notice to the central government, among others, in a case pertaining to the alleged adverse reaction to the COVID-19 vaccine Covishield.

19 Feb 2021

Sri Lanka

Sri Lanka to purchase ten million Covishield doses from India

Sri Lanka will purchase ten million doses of Oxford-AstraZeneca's Covishield vaccine from India, officials have said.

03 Feb 2021


Oxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study

According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.

27 Jan 2021


Sri Lanka to procure two to three million Covishield doses

Sri Lanka will purchase two to three million doses of Oxford-AstraZeneca vaccine, Covishield, from its Indian manufacturing company Serum Institute of India during the next two days, Lalith Weeratunga, the advisor to President Gotabaya Rajapaksa, said on Wednesday.

25 Jan 2021


Bangladesh receives first COVID-19 vaccine consignment from India

Bangladesh on Monday received the first consignment of the five million doses of Covishield vaccines from India under a procurement agreement, four days after New Delhi gifted two million doses of the vaccine to Dhaka.

24 Jan 2021


Coronavirus: Nearly 16 lakh vaccinated in India as pace accelerates

As the first phase of COVID-19 vaccinations is underway in India, nearly 16 lakh healthcare and frontline workers have been inoculated, government data showed.

22 Jan 2021


After SII fire, BCG, rotavirus vaccine production to be hit

Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.

22 Jan 2021


Antonio Guterres saddened by life loss in Serum Institute fire

UN Secretary-General Antonio Guterres is saddened by the loss of life in a fire at the Serum Institute of India (SII) facility in Pune and hopes that the incident is fully investigated, his spokesperson said on Thursday.

21 Jan 2021


Five killed in Serum Institute fire; Maharashtra government orders probe

The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.

21 Jan 2021


Pune: Fire breaks out at Serum Institute of India

On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.

19 Jan 2021


Maldives to become first foreign country to receive Covishield doses

Maldives is set to become the first foreign country to receive COVID-19 vaccines from India. The Asian country will reportedly receive a consignment of Covishield doses on Wednesday.

17 Jan 2021

Madhya Pradesh

Co-WIN app suffers glitches on 1st day of vaccination drive

The COVID-19 Vaccine Intelligence Network (Co-WIN) platform suffered several glitches on the first day of India's vaccination drive.

17 Jan 2021


Meet India's frontline workers who received first COVID-19 vaccine shots

On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.

13 Jan 2021

Delhi Police

Delhi Police steps up security ahead of COVID-19 vaccine roll-out

The Delhi Police has made adequate security arrangements in the city for the smooth transportation of COVID-19 vaccines when the countrywide vaccination roll-out will begin later this week, officials said on Tuesday.

Indians won't get option to choose between Covishield and COVAXIN

The government won't allow beneficiaries to choose between two coronavirus vaccines, that were granted the emergency use approval this month, Union Health Secretary Rajesh Bhushan declared on Tuesday.

12 Jan 2021


First flight with COVID-19 vaccines lands in Delhi from Pune

The first consignment of Covishield vaccines reached Delhi from Pune on Tuesday, four days ahead of the launch of a nationwide drive against the coronavirus.

11 Jan 2021

Narendra Modi

Centre will sponsor vaccination of healthcare, frontline workers: PM Modi

In his first interaction with chief ministers of all states after India approved two vaccines, Prime Minister Narendra Modi said the federal government will sponsor the vaccination of three crore healthcare and frontline workers.

11 Jan 2021

Narendra Modi

Rs. 200 per vaccine dose: SII receives government's purchase order

The Pune-based Serum Institute of India (SII) has received the purchase order for COVID-19 vaccines from the central government, officials said on Monday.

08 Jan 2021

Oxford University

Severe side-effects after COVID-19 vaccine: What are your legal options?

India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).

08 Jan 2021


Coronavirus vaccine consignment awaits government nod for take-off from Pune

On Thursday night, the Pune Airport was prepared to airlift vials of coronavirus vaccine, the first such exercise in India's massive inoculation drive.

05 Jan 2021

Union Health Ministry

Sleeves up! Coronavirus vaccination drive could begin on January 13

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

05 Jan 2021


Global leaders hail India's scientific innovation to combat COVID-19

Global leaders have lauded India's leadership in scientific innovation and decisive action to combat the COVID-19 pandemic.

05 Jan 2021

Adar Poonawalla

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

04 Jan 2021

Oxford University

Bharat Biotech allowed COVAXIN trials on children aged 12+

Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.

04 Jan 2021


Private hospitals may get coronavirus vaccine by March: Serum CEO

While the Indian government has prioritized healthcare workers and high-risk individuals in its vaccine program, doses of the coronavirus vaccine will be available for private companies, hospitals, and individuals by as early as March, the CEO of Serum Institute of India (SII), Adar Poonawalla, said on Sunday.

03 Jan 2021


'Finally paid off,' says Adar Poonawalla after Covishield gets approval

Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.

All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI

Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.

01 Jan 2021


India could approve coronavirus vaccine soon, key meeting today

After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today.

31 Dec 2020

Narendra Modi

Coronavirus: 'Davai bhi, kadaai bhi,' Modi calls for sustained caution

Prime Minister Narendra Modi on Thursday called for sustained caution against COVID-19, even as India looks forward to commencing its vaccination drive soon.

28 Dec 2020


Centre extends COVID-19 surveillance guidelines till January 31

The Ministry of Home Affairs on Monday extended guidelines for COVID-19 surveillance, containment, and caution till January 31, 2021.

28 Dec 2020

Oxford University

Oxford/AstraZeneca vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.

23 Dec 2020


Indian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week

The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, is likely to get approval from the Indian government for emergency use by next week, two people privy to the development told Reuters.

21 Dec 2020

NITI Aayog

Coronavirus vaccination may start in January, says Health Minister

India may begin vaccinating people against coronavirus in January, Union Health Minister Dr. Harsh Vardhan said on Sunday, giving hope to a country that has lost more than a lakh to the fatal disease.

17 Dec 2020

Sri Lanka

India's neighbors train experts for clinical trials of COVID-19 vaccine

India's friendly neighboring nations trained over 100 experts to strengthen capacities in their countries for facilitating phase-3 clinical trials of the Indian COVID-19 vaccine, a senior official of the Department of Biotechnology said.

10 Dec 2020

Apollo Hospitals

Coronavirus: Apollo, prepared to vaccinate one million daily, seeks clarity

Apollo Hospitals Enterprise Ltd., which is India's largest hospital chain, is ready to inoculate one million daily with the coronavirus vaccine but has no clarity from the government.

09 Dec 2020

Bharat Biotech

No emergency approval for SII, Bharat Biotech's vaccine candidates yet

Two applications submitted by the Pune-based Serum Institute of India and Hyderabad-based Bharat Biotech seeking emergency approval for their respective COVID-19 vaccines have not been cleared, NDTV reported on Wednesday.

Now, Bharat Biotech seeks emergency use approval for COVAXIN

After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN.

07 Dec 2020


Serum seeks emergency use approval for Oxford's coronavirus vaccine

Pune-based Serum Institute of India (SII) has sought emergency use authorization from Drugs Controller General of India (DCGI) for the coronavirus vaccine, which is developed by the University of Oxford and the British-pharma giant AstraZeneca, multiple reports said.